News-Medical.Net on MSN
Oxybutynin shows promise in managing hot flashes for prostate cancer patients
A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...
For many years, Richard Sweat’s company, .decimal, has been producing customized medical devices for cancer treatment. Now, the company is testing what could be its most transformative innovation yet, ...
Flash ultra-high dose rate therapy enabled by Varian proton and planning technologies Collaboration between Varian and leading institutions drives progress toward next-generation cancer treatments ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--IntraOp Medical Corporation announced the world's first Phase II Electron FLASH Trial. It marks the first time a randomized trial will compare FLASH radiotherapy* ...
Dot Decimal has developed a new medical device called Flash Therapy that aims to make cancer radiation treatment more targeted and efficient. The innovative device, currently in clinical trials, ...
Vaudois University Hospital (CHUV), in conjunction with the European laboratory for particle physics (CERN) and Theryq SAS, has signed an agreement to develop equipment for a novel radiotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results